Page last updated: 2024-08-21

benzoxazoles and osi 027

benzoxazoles has been researched along with osi 027 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Mohindra, NA; Platanias, LC	1
Kirubakaran, S; Shaik, A	1

Reviews

1 review(s) available for benzoxazoles and osi 027

Article	Year
Evolution of PIKK family kinase inhibitors: A new age cancer therapeutics. Frontiers in bioscience (Landmark edition), 2020, 03-01, Volume: 25, Issue:8 Topics: Benzamides; Benzoxazoles; Humans; Imidazoles; Molecular Targeted Therapy; Morpholines; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Signal Transduction; Triazines	2020

Other Studies

1 other study(ies) available for benzoxazoles and osi 027

Article	Year
Catalytic mammalian target of rapamycin inhibitors as antineoplastic agents. Leukemia & lymphoma, 2015, Volume: 56, Issue:9 Topics: Benzamides; Benzoxazoles; Biocatalysis; Hematologic Neoplasms; Humans; Imidazoles; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Morpholines; Multiprotein Complexes; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome; Triazines	2015

Article

Year

Catalytic mammalian target of rapamycin inhibitors as antineoplastic agents.

Leukemia & lymphoma, 2015, Volume: 56, Issue:9

Topics: Benzamides; Benzoxazoles; Biocatalysis; Hematologic Neoplasms; Humans; Imidazoles; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Morpholines; Multiprotein Complexes; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome; Triazines

2015